217 related articles for article (PubMed ID: 23920063)
1. Erythropoietin combined with ACE inhibitor prevents heart remodeling in 5/6 nephrectomized rats independently of blood pressure and kidney function.
Gut N; Piecha G; Aldebssi F; Schaefer S; Bekeredjian R; Schirmacher P; Ritz E; Gross-Weissmann ML
Am J Nephrol; 2013; 38(2):124-35. PubMed ID: 23920063
[TBL] [Abstract][Full Text] [Related]
2. Chronic kidney disease: cardiac and renal angiotensin-converting enzyme (ACE) 2 expression in rats after subtotal nephrectomy and the effect of ACE inhibition.
Burrell LM; Burchill L; Dean RG; Griggs K; Patel SK; Velkoska E
Exp Physiol; 2012 Apr; 97(4):477-85. PubMed ID: 22198016
[TBL] [Abstract][Full Text] [Related]
3. A combination of Chinese herbs, Astragalus membranaceus var. mongholicus and Angelica sinensis, improved renal microvascular insufficiency in 5/6 nephrectomized rats.
Song J; Meng L; Li S; Qu L; Li X
Vascul Pharmacol; 2009; 50(5-6):185-93. PubMed ID: 19563735
[TBL] [Abstract][Full Text] [Related]
4. Effects of candesartan cilexetil (TCV-116) and enalapril in 5/6 nephrectomized rats.
Noda M; Fukuda R; Matsuo T; Ohta M; Nagano H; Imura Y; Nishikawa K; Shibouta Y
Kidney Int Suppl; 1997 Dec; 63():S136-9. PubMed ID: 9407442
[TBL] [Abstract][Full Text] [Related]
5. Curcumin ameliorates renal failure in 5/6 nephrectomized rats: role of inflammation.
Ghosh SS; Massey HD; Krieg R; Fazelbhoy ZA; Ghosh S; Sica DA; Fakhry I; Gehr TW
Am J Physiol Renal Physiol; 2009 May; 296(5):F1146-57. PubMed ID: 19225048
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D receptor agonist VS-105 improves cardiac function in the presence of enalapril in 5/6 nephrectomized rats.
Wu-Wong JR; Chen YW; Wessale JL
Am J Physiol Renal Physiol; 2015 Feb; 308(4):F309-19. PubMed ID: 25503724
[TBL] [Abstract][Full Text] [Related]
7. Treatment with enalapril and not diltiazem ameliorated progression of chronic kidney disease in rats, and normalized renal AT1 receptor expression as measured with PET imaging.
Ismail B; deKemp RA; Croteau E; Hadizad T; Burns KD; Beanlands RS; DaSilva JN
PLoS One; 2017; 12(5):e0177451. PubMed ID: 28542215
[TBL] [Abstract][Full Text] [Related]
8. Calcitriol ameliorates capillary deficit and fibrosis of the heart in subtotally nephrectomized rats.
Koleganova N; Piecha G; Ritz E; Gross ML
Nephrol Dial Transplant; 2009 Mar; 24(3):778-87. PubMed ID: 18829613
[TBL] [Abstract][Full Text] [Related]
9. [Molecular mechanisms of nephro-protective action of enalapril in experimental chronic renal failure].
Ciechanowicz A
Ann Acad Med Stetin; 1999; Suppl 52():1-93. PubMed ID: 10589103
[TBL] [Abstract][Full Text] [Related]
10. Enalapril in subantihypertensive dosage attenuates kidney proliferation and functional recovery in normotensive ablation nephropathy of the rat.
Krivosíková Z; Sebeková K; Spustová V; Lajdová I; Dzúrik R
Physiol Res; 1999; 48(6):429-35. PubMed ID: 10783907
[TBL] [Abstract][Full Text] [Related]
11. Effect of chronic tetrahydrobiopterin supplementation on blood pressure and proteinuria in 5/6 nephrectomized rats.
Podjarny E; Hasdan G; Bernheim J; Rashid G; Green J; Korzets Z; Bernheim J
Nephrol Dial Transplant; 2004 Sep; 19(9):2223-7. PubMed ID: 15252157
[TBL] [Abstract][Full Text] [Related]
12. Reversal of glomerular lesions involves coordinated restructuring of glomerular microvasculature.
Adamczak M; Gross ML; Amann K; Ritz E
J Am Soc Nephrol; 2004 Dec; 15(12):3063-72. PubMed ID: 15579509
[TBL] [Abstract][Full Text] [Related]
13. Low-dose enalapril reduces angiotensin II and attenuates diabetic-induced cardiac and autonomic dysfunctions.
Malfitano C; De Angelis K; Fernandes T; Wichi RB; Rosa K; Pazzine M; Mostarda C; Ronchi FA; Oliveira EM; Casarini DE; Irigoyen MC
J Cardiovasc Pharmacol; 2012 Jan; 59(1):58-65. PubMed ID: 21921804
[TBL] [Abstract][Full Text] [Related]
14. Effect of L-2286, a poly(ADP-ribose)polymerase inhibitor and enalapril on myocardial remodeling and heart failure.
Bartha E; Kiss GN; Kalman E; Kulcsár G; Kálai T; Hideg K; Habon T; Sumegi B; Toth K; Halmosi R
J Cardiovasc Pharmacol; 2008 Sep; 52(3):253-61. PubMed ID: 18806606
[TBL] [Abstract][Full Text] [Related]
15. Pharmacologic nephrectomy with chronic angiotensin converting enzyme inhibitor treatment in renovascular hypertension in the rat.
Jackson B; Franze L; Sumithran E; Johnston CI
J Lab Clin Med; 1990 Jan; 115(1):21-7. PubMed ID: 2299253
[TBL] [Abstract][Full Text] [Related]
16. High-dose enalapril treatment reverses myocardial fibrosis in experimental uremic cardiomyopathy.
Tyralla K; Adamczak M; Benz K; Campean V; Gross ML; Hilgers KF; Ritz E; Amann K
PLoS One; 2011 Jan; 6(1):e15287. PubMed ID: 21298056
[TBL] [Abstract][Full Text] [Related]
17. Effect of enalapril on haemoglobin and serum erythropoietin in patients with chronic nephropathy.
Kamper AL; Nielsen OJ
Scand J Clin Lab Invest; 1990 Oct; 50(6):611-8. PubMed ID: 2247767
[TBL] [Abstract][Full Text] [Related]
18. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin.
Lebel M; Rodrigue ME; Agharazii M; Larivière R
Am J Hypertens; 2006 Dec; 19(12):1286-92. PubMed ID: 17161776
[TBL] [Abstract][Full Text] [Related]
19. Erythropoietin induces neovascularization and improves cardiac function in rats with heart failure after myocardial infarction.
van der Meer P; Lipsic E; Henning RH; Boddeus K; van der Velden J; Voors AA; van Veldhuisen DJ; van Gilst WH; Schoemaker RG
J Am Coll Cardiol; 2005 Jul; 46(1):125-33. PubMed ID: 15992646
[TBL] [Abstract][Full Text] [Related]
20. Halofuginone reduces the occurrence of renal fibrosis in 5/6 nephrectomized rats.
Benchetrit S; Yarkoni S; Rathaus M; Pines M; Rashid G; Bernheim J; Bernheim J
Isr Med Assoc J; 2007 Jan; 9(1):30-4. PubMed ID: 17274353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]